Previously used to treat HIV and Hepatitis B, nucleoside reverse transcriptase inhibitors (NRTIs) reduced the risk of ...

Operator: Ladies and gentlemen, welcome to the Evotec SE Quarterly Statement Q1 2025 Conference Call. I am George, the Chorus ...

Companion Diagnostics Market is Segmented by Type (Immunohistochemistry, Molecular Diagnosis), by Application (Oncology, Cardiovascular, Central ...

Unlike other pathologies, amyotrophic lateral sclerosis (ALS) cannot be reproduced accurately in animal models, complicating ...

Bioengineers at Queen Mary University of London have taken a significant step forward in the development of laboratory-based ...

Researchers at the Paul Scherrer Institute PSI have developed an AI that could open up a new, cost-effective approach to ...

A study published in the journal Cell marks the first reported instance of generative AI designing synthetic molecules that ...

The medical research on human subjects has to respect the ethical principles included in the Declaration of Helsinki and the additional constraints imposed ...

New research shows that the gum disease bacterium P. gingivalis can slip into the bloodstream and infiltrate the heart. There ...

The increasing implication of glial cells in neurodegenerative diseases makes them an appealing addition to iPSC-based model systems for investigating disease mechanisms. Over the last decade, Dr.

Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and other treatments for ophthalmic disorders ...

A study published today in the journal Cell marks the first reported instance of generative AI designing synthetic molecules that can successfully control gene expression in healthy mammalian cells.